Erstellt von conna
Amgen Inc. diskutieren
Amgen Inc.
WKN: 867900 / Symbol: AMGN / Name: Amgen / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
277,10 €
-0,23 %
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Piper Sandler from $329.00 to $328.00. They now have an "overweight" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $328.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Bank of America Corporation from $252.00 to $261.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Piper Sandler from $328.00 to $342.00. They now have an "overweight" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Bank of America Corporation from $261.00 to $272.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $405.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Piper Sandler from $342.00 to $381.00. They now have an "overweight" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Daiwa Capital Markets from $310.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its price target raised by analysts at HSBC Holdings plc from $343.00 to $381.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen (NASDAQ:AMGN) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat
Neueste Beiträge
jessicaohara in Binance Founder CZ Refused a President’s Token Listing Request – Here’s Why It Matters, Binance Coin